Partnology https://validator.w3.org/feed/docs/rss2.html Pranav Sharma, Founder and CEO of Xosomix Cellares raises $257M Series D, Eikon files for IPO, Tenpoint wins FDA approval Mendra launches with $82M Series A, RAPT acquired by GSK, Janux signs deal with BMS Soley raises $200M Series C, Lux Capital raises $1.5B fund, Cartography signs $850M+ deal with Pfizer Dynavax acquired by Sanofi, Ultragenyx late-stage failure, Crinetics posts strong sales Ambros launches with $125M, Clavis forms $7.25B collaboration with Fosun, BioMarin acquires Amicus Chai Discovery raises $130M Series B, Dren Bio lands $100M Sanofi deal, Arthrosi acquired by Sobi Immix raises $100M, Mirum acquires Bluejay, FDA moves to phase out primate testing Cyril De Colle, Cofounder & CSO at Neurogastrx Gary Li, Chief Strategy / Scientific Officer, Venture Advisor Samuel Collins, CMO at Mahzi Therapeutics Aspen Neuro raises $115M, Gilead acquires Sprint Bio, Cytokinetics nears FDA approval Solve raises $120M, Metagenomi cuts 25% of staff, Day One acquires Mersana Braveheart Bio raises $185M, A2 Bio CAR-T complete response in lung cancer, Rigel loses Eli Lilly partnership Genentech cuts 118 roles, Neurocrine signs $880M deal with TransThera, Evommune targets $150M IPO Chorom Pak, CEO of LynxBio John Langowski, CSO at Micoy Therapeutics Protego raises $130M Series B, Cormorant targets $400M Fund Michael Mahler, CSO of Exagen John Fair, CEO of J3 Bioscience Electra raises $183M, Akero aquired by Novo, MapLight lands $250M IPO Kardigan raises $254M, Kezar plans layoffs, Kite and Pregene ink $1.52B cell therapy deal Apogee raises $345M, Ascenta Capital closes $325M fund, MapLight files for IPO TCGX Raises $1.3B Fund, BridgeBio spins out GondolaBio with $300M, Halozyme acquires Elektrofi Patient Square Capital $3.1B fund, Replicate lands $550M Novo deal, Enlaza partners with Vertex Craig Parker, CEO of Surrozen Atlas Venture raises $400M, Braveheart Bio licenses $1B+ cardio drug, FDA vaccine advisory shakeup Camilla Simpson, CEO of Zehna Therapeutics Derrell Porter, CEO of cTRL Therapeutics Ridge Bio launches with $25M, LB Pharma $285M IPO, aTyr Pharma stock drops 80% Avenzo raises $60M Series B, ArsenalBio halves workforce, Kalexo Bio $1B licensing deal Mission BioCapital raises $134M for biotech fund, Sanofi Ventures expands biotech investment, 89bio acquired by Roche Arnatar emerges from Stealth, Kite aquires Interius Bio, Ionis wins FDA approval Kriya raises $313M, Oric lays off 20%, Kumquat strikes $1.3B deal with Bayer $1.86B OrbiMed Fund, Iovance and Poseida layoffs, 10x Genomics acquires Scale Bio Radiopharma’s Moment: Highlights from the TRP Summit and Market Moves Shaping 2025 Ranjan Batra, CSO of Dyne Therapeutics Eswar Iyer, CEO of Aikium Nathalie Dubois-Stringfellow, CDO of Sangamo Therapeutics Kartik Krishnan, CEO of OncoNano Venkataraman Sriram, CSO of Foundery Biosciences Frazier Life Sciences $1.3B Fund, LTZ partners with Lilly, Actio Bio earns FDA Fast Track John Byon, CMO of Imugene Limited Insights Robin Mansukhani, CEO of Deciduous Therapeutics MapLight $372M Series D, TCG Labs Soleil doubles fund to $800M, Gate Bioscience signs $856M deal with Eli Lilly Omega closes $647M fund, Concentra acquires iTeos, FDA appoints new Head of CDER Biotech Market Outlook (Industry-wide): Q2 Snapshot Highlights Mixed Fortunes Judy Chou, President & CEO of AltruBio Partnology